Papers/PMID:34664527
The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology2022The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
coenzyme Q10 — decreases C-reactive protein concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×2“The supplementation of CoQ10 decreased significantly the scores of Beck Depression Inventory (BDI) (p = .03) and Beck Anxiety Inventory (BAI) (p = .01) and high-sensitivity C-reactive protein (hs-CRP) level (p = .005) when comparing with the placebo group.”
Quoted verbatim from The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.. - Study
- RCT
- Duration
- 3 months
- Dose
- 100 mg/day CoQ10, 12 weeks
- Population
- Women with polycystic ovary syndrome (PCOS), aged 18-40 years
The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.2022PMID:34664527